Treatment of Enterotoxigenic and EnteropathogenicEscherichia coli-induced Diarrhoea in Children with Bovine Immunoglobulin Milk Concentrate from Hyperimmunized Cows: A Double-blind, Placebo-controlled, Clinical Trial
- 1 January 2000
- journal article
- clinical trial
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 35 (7) , 711-718
- https://doi.org/10.1080/003655200750023372
Abstract
Background: Enterotoxigenic Escherichia coli (ETEC) and enteropathogenic Escherichia coli (EPEC) are important causes of diarrhoea in young children and are associated with significant mortality rates. Passive immunization with antibodies from immunized cows has previously been shown to be effective as prophylaxis against E. coli-induced diarrhoea and therapeutically against rotavirus and cryptosporidia-induced diarrhoea. Methods: We tested the therapeutic efficacy of an oral bovine immunoglobulin milk concentrate (BIC) from cows hyperimmunized with ETEC and EPEC strains, in a randomized, placebo-controlled study in children with E. coli-induced diarrhoea. Eighty-six children between 4-24 months of age attending the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) with E. coli-induced diarrhoea (63 EPEC/ETEC and 23 with other diarrhoeagenic E. coli) were randomly assigned to receive orally administered BIC (20 g) containing anti-ETEC/EPEC antibodies or a placebo preparation daily for 4 consecutive days. Daily stool output, intake of oral rehydration solution (ORS), stool frequency, and presence of diarrhoeagenic E. coli strains in the stool were monitored for 4 days. Results: Children in the treatment group tolerated the BIC with no side effects. There were no significant differences between the two groups with regard to ORS intake, stool output, frequency of diarrhoea, or clearance of pathogen. Nor was there any significant alteration in the duration of diarrhoea. Conclusions: In contrast to the prophylactic efficacy of anti-E. coli BIC and the therapeutic efficacy of a similarly prepared anti-rotavirus BIC, antibodies from hyperimmunized cows appear to have no significant therapeutic benefit in the treatment of acute diarrhoea due to EPEC/ETEC.Keywords
This publication has 22 references indexed in Scilit:
- Bovine Colostrum Ameliorates Diarrhea in Infection with Diarrheagenic Escherichia coli, Shiga Toxin-Producing E. coli, and E. coli Expressing Intimin and HemolysinJournal of Pediatric Gastroenterology and Nutrition, 1999
- DiarrheagenicEscherichia coliClinical Microbiology Reviews, 1998
- Infectious Agents Causing Acute Watery Diarrhoea in Infants and Young Children in Bangladesh and their Public Health ImplicationsJournal of Tropical Pediatrics, 1994
- Impact of Zinc Supplementation on Intestinal Permeability in Bangladeshi Children with Acute Diarrhoea and Persistent Diarrhoea SyndromeJournal of Pediatric Gastroenterology and Nutrition, 1992
- Epidemiology of Travelers' Diarrhea and Relative Importance of Various PathogensClinical Infectious Diseases, 1990
- Use of Bovine Milk Concentrate Containing Antibody to Rotavirus to Treat Rotavirus Gastroenteritis in InfantsThe Journal of Infectious Diseases, 1987
- Escherichia coli that Cause Diarrhea: Enterotoxigenic, Enteropathogenic, Enteroinvasive, Enterohemorrhagic, and EnteroadherentThe Journal of Infectious Diseases, 1987
- Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibodyMedical Microbiology and Immunology, 1985
- ENTEROPATHOGENIC ESCHERICHIA COLI OF CLASSIC SEROTYPES ASSOCIATED WITH INFANT DIARRHEA: EPIDEMIOLOGY AND PATHOGENESISEpidemiologic Reviews, 1984
- Surveillance of patients attending a diarrhoeal disease hospital in BangladeshBMJ, 1982